97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012
HB1528

 

Introduced 2/15/2011, by Rep. Lou Lang

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/303.05
720 ILCS 570/311.5 new
720 ILCS 570/312  from Ch. 56 1/2, par. 1312

    Amends the Illinois Controlled Substances Act. Makes various changes relating to mid-level practitioner registration. Provides that a prescriber who is otherwise authorized to prescribe controlled substances in Illinois may issue an electronic prescription for Schedule II, III, IV, and V controlled substances if done in accordance with federal rules for electronic prescriptions for controlled substances. Provides that physicians may issue multiple prescriptions (3 sequential 30-day supplies) for the same Schedule II controlled substances authorizing up to a 90-day supply. Makes other changes.


LRB097 08734 RLC 48863 b

 

 

A BILL FOR

 

HB1528LRB097 08734 RLC 48863 b

1    AN ACT concerning controlled substances.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Sections 303.05 and 312 and by adding
6Section 311.5 as follows:
 
7    (720 ILCS 570/303.05)
8    Sec. 303.05. Mid-level practitioner registration.
9    (a) The Department of Financial and Professional
10Regulation shall register licensed physician assistants and
11licensed advanced practice nurses to prescribe and dispense
12controlled substances under Section 303 and euthanasia
13agencies to purchase, store, or administer animal euthanasia
14drugs under the following circumstances:
15        (1) with respect to physician assistants,
16            (A) the physician assistant has been delegated
17        written authority to prescribe any Schedule III
18        through V controlled substances by a physician
19        licensed to practice medicine in all its branches in
20        accordance with Section 7.5 of the Physician Assistant
21        Practice Act of 1987; and the physician assistant has
22        completed the appropriate application forms and has
23        paid the required fees as set by rule; or

 

 

HB1528- 2 -LRB097 08734 RLC 48863 b

1            (B) the physician assistant has been delegated
2        authority by a supervising physician licensed to
3        practice medicine in all its branches to prescribe or
4        dispense Schedule II controlled substances through a
5        written delegation of authority and under the
6        following conditions:
7                (i) no more than 5 Schedule II controlled
8            substances by oral dosage may be delegated;
9                (ii) any delegation must be of controlled
10            substances prescribed by the supervising
11            physician;
12                (iii) all prescriptions must be limited to no
13            more than a 30-day oral dosage, with any
14            continuation authorized only after prior approval
15            of the supervising physician;
16                (iv) the physician assistant must discuss the
17            condition of any patients for whom a controlled
18            substance is prescribed monthly with the
19            delegating physician; and
20                (v) the physician assistant must have
21            completed the appropriate application forms and
22            paid the required fees as set by rule;
23        (2) with respect to advanced practice nurses,
24            (A) the advanced practice nurse has been delegated
25        authority to prescribe any Schedule III through V
26        controlled substances by a physician licensed to

 

 

HB1528- 3 -LRB097 08734 RLC 48863 b

1        practice medicine in all its branches or a podiatrist
2        in accordance with Sections 65-35 and Section 65-40 of
3        the Nurse Practice Act. The advanced practice nurse has
4        completed the appropriate application forms and has
5        paid the required fees as set by rule; or
6            (B) the advanced practice nurse has been delegated
7        authority by a collaborating physician licensed to
8        practice medicine in all its branches to prescribe or
9        dispense Schedule II controlled substances through a
10        written delegation of authority and under the
11        following conditions:
12                (i) no more than 5 Schedule II controlled
13            substances by oral dosage may be delegated;
14                (ii) any delegation must be of controlled
15            substances prescribed by the collaborating
16            physician;
17                (iii) all prescriptions must be limited to no
18            more than a 30-day oral dosage, with any
19            continuation authorized only after prior approval
20            of the collaborating physician;
21                (iv) the advanced practice nurse must discuss
22            the condition of any patients for whom a controlled
23            substance is prescribed monthly with the
24            delegating physician or in the course of review as
25            required by the Nurse Practice Act; and
26                (v) the advanced practice nurse must have

 

 

HB1528- 4 -LRB097 08734 RLC 48863 b

1            completed the appropriate application forms and
2            paid the required fees as set by rule; or
3        (3) with respect to animal euthanasia agencies, the
4    euthanasia agency has obtained a license from the
5    Department of Financial and Professional Regulation and
6    obtained a registration number from the Department.
7    (b) The mid-level practitioner shall only be licensed to
8prescribe those schedules of controlled substances for which a
9licensed physician or licensed podiatrist has delegated
10prescriptive authority, except that an animal euthanasia
11agency does not have any prescriptive authority. A physician
12assistant and an advanced practice nurse are prohibited from
13prescribing medications and controlled substances not set
14forth in the required written delegation of authority.
15    (c) Upon completion of all registration requirements,
16physician assistants, advanced practice nurses, and animal
17euthanasia agencies may shall be issued a mid-level
18practitioner controlled substances license for Illinois.
19(Source: P.A. 95-639, eff. 10-5-07; 96-189, eff. 8-10-09;
2096-268, eff. 8-11-09; 96-1000, eff. 7-2-10.)
 
21    (720 ILCS 570/311.5 new)
22    Sec. 311.5. Electronic prescriptions for controlled
23substances. Notwithstanding any other Section in this Act, a
24prescriber who is otherwise authorized to prescribe controlled
25substances in Illinois may issue an electronic prescription for

 

 

HB1528- 5 -LRB097 08734 RLC 48863 b

1Schedule II, III, IV, and V controlled substances if done in
2accordance with the federal rules for electronic prescriptions
3for controlled substances, as set forth in 21 C.F.R. Parts
41300, 1304, 1306, and 1311.
 
5    (720 ILCS 570/312)  (from Ch. 56 1/2, par. 1312)
6    Sec. 312. Requirements for dispensing controlled
7substances.
8    (a) A practitioner, in good faith, may dispense a Schedule
9II controlled substance, which is a narcotic drug listed in
10Section 206 of this Act; or which contains any quantity of
11amphetamine or methamphetamine, their salts, optical isomers
12or salts of optical isomers; phenmetrazine and its salts; or
13pentazocine; and Schedule III, IV, or V controlled substances
14to any person upon a written or electronic prescription of any
15prescriber, dated and signed by the person prescribing (or
16electronically validated in compliance with Section 311.5) on
17the day when issued and bearing the name and address of the
18patient for whom, or the owner of the animal for which the
19controlled substance is dispensed, and the full name, address
20and registry number under the laws of the United States
21relating to controlled substances of the prescriber, if he or
22she is required by those laws to be registered. If the
23prescription is for an animal it shall state the species of
24animal for which it is ordered. The practitioner filling the
25prescription shall, unless otherwise permitted, write the date

 

 

HB1528- 6 -LRB097 08734 RLC 48863 b

1of filling and his or her own signature on the face of the
2written prescription or, alternatively, shall indicate such
3filling using a unique identifier as defined in paragraph (v)
4of Section 3 of the Pharmacy Practice Act. The written
5prescription shall be retained on file by the practitioner who
6filled it or pharmacy in which the prescription was filled for
7a period of 2 years, so as to be readily accessible for
8inspection or removal by any officer or employee engaged in the
9enforcement of this Act. Whenever the practitioner's or
10pharmacy's copy of any prescription is removed by an officer or
11employee engaged in the enforcement of this Act, for the
12purpose of investigation or as evidence, such officer or
13employee shall give to the practitioner or pharmacy a receipt
14in lieu thereof. If the specific prescription is machine or
15computer generated and printed at the prescriber's office, the
16date does not need to be handwritten. A prescription for a
17Schedule II controlled substance shall not be issued for filled
18more than a 30 day supply, except as provided in subsection
19(a-5), and shall be valid for up to 90 days after the date of
20issuance. A written prescription for Schedule III, IV or V
21controlled substances shall not be filled or refilled more than
226 months after the date thereof or refilled more than 5 times
23unless renewed, in writing, by the prescriber.
24    (a-5) Physicians may issue multiple prescriptions (3
25sequential 30-day supplies) for the same Schedule II controlled
26substance, authorizing up to a 90-day supply. Before

 

 

HB1528- 7 -LRB097 08734 RLC 48863 b

1authorizing a 90-day supply of a Schedule II controlled
2substance, the physician must meet both of the following
3conditions:
4        (1) Each separate prescription must be issued for a
5    legitimate medical purpose by an individual physician
6    acting in the usual course of professional practice.
7        (2) The individual physician must provide written
8    instructions on each prescription (other than the first
9    prescription, if the prescribing physician intends for the
10    prescription to be filled immediately) indicating the
11    earliest date on which a pharmacy may fill that
12    prescription.
13    (b) In lieu of a written prescription required by this
14Section, a pharmacist, in good faith, may dispense Schedule
15III, IV, or V substances to any person either upon receiving a
16facsimile of a written, signed prescription transmitted by the
17prescriber or the prescriber's agent or upon a lawful oral
18prescription of a prescriber which oral prescription shall be
19reduced promptly to writing by the pharmacist and such written
20memorandum thereof shall be dated on the day when such oral
21prescription is received by the pharmacist and shall bear the
22full name and address of the ultimate user for whom, or of the
23owner of the animal for which the controlled substance is
24dispensed, and the full name, address, and registry number
25under the law of the United States relating to controlled
26substances of the prescriber prescribing if he or she is

 

 

HB1528- 8 -LRB097 08734 RLC 48863 b

1required by those laws to be so registered, and the pharmacist
2filling such oral prescription shall write the date of filling
3and his or her own signature on the face of such written
4memorandum thereof. The facsimile copy of the prescription or
5written memorandum of the oral prescription shall be retained
6on file by the proprietor of the pharmacy in which it is filled
7for a period of not less than two years, so as to be readily
8accessible for inspection by any officer or employee engaged in
9the enforcement of this Act in the same manner as a written
10prescription. The facsimile copy of the prescription or oral
11prescription and the written memorandum thereof shall not be
12filled or refilled more than 6 months after the date thereof or
13be refilled more than 5 times, unless renewed, in writing, by
14the prescriber.
15    (c) Except for any non-prescription targeted
16methamphetamine precursor regulated by the Methamphetamine
17Precursor Control Act, a controlled substance included in
18Schedule V shall not be distributed or dispensed other than for
19a medical purpose and not for the purpose of evading this Act,
20and then:
21        (1) only personally by a person registered to dispense
22    a Schedule V controlled substance and then only to his or
23    her patients, or
24        (2) only personally by a pharmacist, and then only to a
25    person over 21 years of age who has identified himself or
26    herself to the pharmacist by means of 2 positive documents

 

 

HB1528- 9 -LRB097 08734 RLC 48863 b

1    of identification.
2        (3) the dispenser shall record the name and address of
3    the purchaser, the name and quantity of the product, the
4    date and time of the sale, and the dispenser's signature.
5        (4) no person shall purchase or be dispensed more than
6    120 milliliters or more than 120 grams of any Schedule V
7    substance which contains codeine, dihydrocodeine, or any
8    salts thereof, or ethylmorphine, or any salts thereof, in
9    any 96 hour period. The purchaser shall sign a form,
10    approved by the Department of Financial and Professional
11    Regulation, attesting that he or she has not purchased any
12    Schedule V controlled substances within the immediately
13    preceding 96 hours.
14        (5) (Blank). a copy of the records of sale, including
15    all information required by paragraph (3), shall be
16    forwarded to the Department of Professional Regulation at
17    its principal office by the 15th day of the following
18    month.
19        (6) all records of purchases and sales shall be
20    maintained for not less than 2 years.
21        (7) no person shall obtain or attempt to obtain within
22    any consecutive 96 hour period any Schedule V substances of
23    more than 120 milliliters or more than 120 grams containing
24    codeine, dihydrocodeine or any of its salts, or
25    ethylmorphine or any of its salts. Any person obtaining any
26    such preparations or combination of preparations in excess

 

 

HB1528- 10 -LRB097 08734 RLC 48863 b

1    of this limitation shall be in unlawful possession of such
2    controlled substance.
3        (8) a person qualified to dispense controlled
4    substances under this Act and registered thereunder shall
5    at no time maintain or keep in stock a quantity of Schedule
6    V controlled substances defined and listed in Section 212
7    (b) (1), (2) or (3) in excess of 4.5 liters for each
8    substance; a pharmacy shall at no time maintain or keep in
9    stock a quantity of Schedule V controlled substances as
10    defined in excess of 4.5 liters for each substance, plus
11    the additional quantity of controlled substances necessary
12    to fill the largest number of prescription orders filled by
13    that pharmacy for such controlled substances in any one
14    week in the previous year. These limitations shall not
15    apply to Schedule V controlled substances which Federal law
16    prohibits from being dispensed without a prescription.
17        (9) no person shall distribute or dispense butyl
18    nitrite for inhalation or other introduction into the human
19    body for euphoric or physical effect.
20    (d) Every practitioner shall keep a record or log of
21controlled substances received by him or her and a record of
22all such controlled substances administered, dispensed or
23professionally used by him or her otherwise than by
24prescription. It shall, however, be sufficient compliance with
25this paragraph if any practitioner utilizing controlled
26substances listed in Schedules III, IV and V shall keep a

 

 

HB1528- 11 -LRB097 08734 RLC 48863 b

1record of all those substances dispensed and distributed by him
2or her other than those controlled substances which are
3administered by the direct application of a controlled
4substance, whether by injection, inhalation, ingestion, or any
5other means to the body of a patient or research subject. A
6practitioner who dispenses, other than by administering, a
7controlled substance in Schedule II, which is a narcotic drug
8listed in Section 206 of this Act, or which contains any
9quantity of amphetamine or methamphetamine, their salts,
10optical isomers or salts of optical isomers, pentazocine, or
11methaqualone shall do so only upon the issuance of a written
12prescription blank or electronic prescription issued by a
13prescriber.
14    (e) Whenever a manufacturer distributes a controlled
15substance in a package prepared by him or her, and whenever a
16wholesale distributor distributes a controlled substance in a
17package prepared by him or her or the manufacturer, he or she
18shall securely affix to each package in which that substance is
19contained a label showing in legible English the name and
20address of the manufacturer, the distributor and the quantity,
21kind and form of controlled substance contained therein. No
22person except a pharmacist and only for the purposes of filling
23a prescription under this Act, shall alter, deface or remove
24any label so affixed.
25    (f) Whenever a practitioner dispenses any controlled
26substance except a non-prescription Schedule V product or a

 

 

HB1528- 12 -LRB097 08734 RLC 48863 b

1non-prescription targeted methamphetamine precursor regulated
2by the Methamphetamine Precursor Control Act, he or she shall
3affix to the container in which such substance is sold or
4dispensed, a label indicating the date of initial filling, the
5practitioner's name and address, the name of the patient, the
6name of the prescriber, the directions for use and cautionary
7statements, if any, contained in any prescription or required
8by law, the proprietary name or names or the established name
9of the controlled substance, and the dosage and quantity,
10except as otherwise authorized by regulation by the Department
11of Financial and Professional Regulation. No person shall
12alter, deface or remove any label so affixed as long as the
13specific medication remains in the container.
14    (g) A person to whom or for whose use any controlled
15substance has been prescribed or dispensed by a practitioner,
16or other persons authorized under this Act, and the owner of
17any animal for which such substance has been prescribed or
18dispensed by a veterinarian, may lawfully possess such
19substance only in the container in which it was delivered to
20him or her by the person dispensing such substance.
21    (h) The responsibility for the proper prescribing or
22dispensing of controlled substances that are under the
23prescriber's direct control is upon the prescriber. The and the
24responsibility for the proper filling of a prescription for
25controlled substance drugs rests with the pharmacist. An order
26purporting to be a prescription issued to any individual, which

 

 

HB1528- 13 -LRB097 08734 RLC 48863 b

1is not in the regular course of professional treatment nor part
2of an authorized methadone maintenance program, nor in
3legitimate and authorized research instituted by any
4accredited hospital, educational institution, charitable
5foundation, or federal, state or local governmental agency, and
6which is intended to provide that individual with controlled
7substances sufficient to maintain that individual's or any
8other individual's physical or psychological addiction,
9habitual or customary use, dependence, or diversion of that
10controlled substance is not a prescription within the meaning
11and intent of this Act; and the person issuing it, shall be
12subject to the penalties provided for violations of the law
13relating to controlled substances.
14    (i) A prescriber shall not preprint or cause to be
15preprinted a prescription for any controlled substance; nor
16shall any practitioner issue, fill or cause to be issued or
17filled, a preprinted prescription for any controlled
18substance.
19    (i-5) A prescriber may use a machine or electronic device
20to individually generate a printed prescription, but the
21prescriber is still required to affix his or her manual
22signature.
23    (j) No person shall manufacture, dispense, deliver,
24possess with intent to deliver, prescribe, or administer or
25cause to be administered under his or her direction any
26anabolic steroid, for any use in humans other than the

 

 

HB1528- 14 -LRB097 08734 RLC 48863 b

1treatment of disease in accordance with the order of a
2physician licensed to practice medicine in all its branches for
3a valid medical purpose in the course of professional practice.
4The use of anabolic steroids for the purpose of hormonal
5manipulation that is intended to increase muscle mass, strength
6or weight without a medical necessity to do so, or for the
7intended purpose of improving physical appearance or
8performance in any form of exercise, sport, or game, is not a
9valid medical purpose or in the course of professional
10practice.
11(Source: P.A. 96-166, eff. 1-1-10.)